Literature DB >> 29408023

Broad anti-herpesviral activity of α-hydroxytropolones.

Shannon D Dehghanpir1, Claire H Birkenheuer1, Kui Yang1, Ryan P Murelli2, Lynda A Morrison3, Stuart F J Le Grice4, Joel D Baines5.   

Abstract

Herpesviruses are ubiquitous in animals and cause economic losses concomitant with many diseases. Most of the domestic animal herpesviruses are within the subfamily Alphaherpesvirinae, which includes human herpes simplex virus 1 (HSV-1). Suppression of HSV-1 replication has been reported with α-hydroxytropolones (αHTs), aromatic ring compounds that have broad bioactivity due to potent chelating activity. It is postulated that αHTs inhibit enzymes within the nucleotidyltransferase superfamily (NTS). These enzymes require divalent cations for nucleic acid cleavage activity. Potential targets include the nuclease component of the herpesvirus terminase (pUL15C), a highly conserved NTS-like enzyme that cleaves viral DNA into genomic lengths prior to packaging into capsids. Inhibition of pUL15C activity in biochemical assays by various αHTs previously revealed a spectrum of potencies. Interestingly, the most potent anti-pUL15C αHT inhibited HSV-1 replication to a limited extent in cell culture. The aim of this study was to evaluate three different αHT molecules with varying biochemical anti-pUL15C activity for a capacity to inhibit replication of veterinary herpesviruses (BoHV-1, EHV-1, and FHV-1) and HSV-1. Given the known discordant potencies between anti-pUL15C and HSV-1 replication inhibition, a second objective was to elucidate the mechanism of action of these compounds. The results show that αHTs broadly inhibit herpesviruses, with similar inhibitory effect against HSV-1, BoHV-1, EHV-1, and FHV-1. Based on immunoblotting, Southern blotting, and real-time qPCR, the compounds were found to specifically inhibit viral DNA replication. Thus, αHTs represent a new class of broadly active anti-herpesviral compounds with potential veterinary applications.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-herpesvirus; Herpesvirus; Nucleotidyltransferase superfamily; α-hydroxytropolones

Mesh:

Substances:

Year:  2017        PMID: 29408023      PMCID: PMC6292515          DOI: 10.1016/j.vetmic.2017.12.016

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  32 in total

Review 1.  A fresh look at natural tropolonoids.

Authors:  Ronald Bentley
Journal:  Nat Prod Rep       Date:  2007-11-22       Impact factor: 13.423

2.  Triflic acid-mediated rearrangements of 3-methoxy-8-oxabicyclo[3.2.1]octa-3,6-dien-2-ones: synthesis of methoxytropolones and furans.

Authors:  Yvonne D Williams; Christine Meck; Noushad Mohd; Ryan P Murelli
Journal:  J Org Chem       Date:  2013-11-14       Impact factor: 4.354

3.  The herpes simplex virus 1 UL51 gene product has cell type-specific functions in cell-to-cell spread.

Authors:  Richard J Roller; Alison C Haugo; Kui Yang; Joel D Baines
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

4.  A mutation in UL15 of herpes simplex virus 1 that reduces packaging of cleaved genomes.

Authors:  Kui Yang; Elizabeth G Wills; Joel D Baines
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

5.  Oral administration of famciclovir for treatment of spontaneous ocular, respiratory, or dermatologic disease attributed to feline herpesvirus type 1: 59 cases (2006-2013).

Authors:  Sara M Thomasy; Olivia Shull; Catherine A Outerbridge; Christine C Lim; Kate S Freeman; Ann R Strom; Philip H Kass; David J Maggs
Journal:  J Am Vet Med Assoc       Date:  2016-09-01       Impact factor: 1.936

6.  Inhibition of the ANT(2")-Ia resistance enzyme and rescue of aminoglycoside antibiotic activity by synthetic α-hydroxytropolones.

Authors:  Danielle R Hirsch; Georgina Cox; Michael P D'Erasmo; Tushar Shakya; Christine Meck; Noushad Mohd; Gerard D Wright; Ryan P Murelli
Journal:  Bioorg Med Chem Lett       Date:  2014-09-19       Impact factor: 2.823

7.  Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody.

Authors:  Adalbert Krawczyk; Michaela A E Arndt; Ludger Grosse-Hovest; Wilko Weichert; Bernd Giebel; Ulf Dittmer; Hartmut Hengel; Dirk Jäger; Karl E Schneweis; Anna M Eis-Hübinger; Michael Roggendorf; Jürgen Krauss
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

8.  Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats.

Authors:  Jennifer P Fontenelle; Cynthia C Powell; Julia K Veir; Steven V Radecki; Michael R Lappin
Journal:  Am J Vet Res       Date:  2008-02       Impact factor: 1.156

Review 9.  Herpes simplex: insights on pathogenesis and possible vaccines.

Authors:  David M Koelle; Lawrence Corey
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

10.  The HSV-1 exonuclease, UL12, stimulates recombination by a single strand annealing mechanism.

Authors:  April J Schumacher; Kareem N Mohni; Yinan Kan; Eric A Hendrickson; Jeremy M Stark; Sandra K Weller
Journal:  PLoS Pathog       Date:  2012-08-09       Impact factor: 6.823

View more
  9 in total

1.  Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands.

Authors:  Jennifer T Miller; Haiyan Zhao; Takashi Masaoka; Brittany Varnado; Elena M Cornejo Castro; Vickie A Marshall; Kaivon Kouhestani; Anna Y Lynn; Keith E Aron; Anqi Xia; John A Beutler; Danielle R Hirsch; Liang Tang; Denise Whitby; Ryan P Murelli; Stuart F J Le Grice
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

2.  Importance of lipophilicity for potent anti-herpes simplex virus-1 activity of α-hydroxytropolones.

Authors:  Alex J Berkowitz; Abaigeal D Franson; Andreu Gazquez Cassals; Katherine A Donald; Alice J Yu; Aswin K Garimallaprabhakaran; Lynda A Morrison; Ryan P Murelli
Journal:  Medchemcomm       Date:  2019-05-30       Impact factor: 3.597

3.  Troponoid Atropisomerism: Studies on the Configurational Stability of Tropone-Amide Chiral Axes.

Authors:  Danielle R Hirsch; Anthony J Metrano; Elizabeth A Stone; Golo Storch; Scott J Miller; Ryan P Murelli
Journal:  Org Lett       Date:  2019-03-14       Impact factor: 6.005

4.  Synthesis of Polyoxygenated Tropolones and their Antiviral Activity against Hepatitis B Virus and Herpes Simplex Virus-1.

Authors:  Daniel V Schiavone; Diana M Kapkayeva; Qilan Li; Molly E Woodson; Andreu Gazquez Casals; Lynda A Morrison; John E Tavis; Ryan P Murelli
Journal:  Chemistry       Date:  2022-01-31       Impact factor: 5.236

5.  ICP22 of Herpes Simplex Virus 1 Decreases RNA Polymerase Processivity.

Authors:  Claire H Birkenheuer; Laura Dunn; Rachel Dufour; Joel D Baines
Journal:  J Virol       Date:  2022-01-12       Impact factor: 6.549

6.  The HIV Integrase Inhibitor Raltegravir Inhibits Felid Alphaherpesvirus 1 Replication by Targeting both DNA Replication and Late Gene Expression.

Authors:  Matthew R Pennington; Ian E H Voorhees; Heather M Callaway; Shannon D Dehghanpir; Joel D Baines; Colin R Parrish; Gerlinde R Van de Walle
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

7.  RNA Polymerase II Promoter-Proximal Pausing and Release to Elongation Are Key Steps Regulating Herpes Simplex Virus 1 Transcription.

Authors:  Claire H Birkenheuer; Joel D Baines
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

8.  Divergent synthesis of a thiolate-based α-hydroxytropolone library with a dynamic bioactivity profile.

Authors:  Nana B Agyemang; Cassandra R Kukla; Tiffany C Edwards; Qilan Li; Madison K Langen; Alexandra Schaal; Abaigeal D Franson; Andreu Gazquez Casals; Katherine A Donald; Alice J Yu; Maureen J Donlin; Lynda A Morrison; John E Tavis; Ryan P Murelli
Journal:  RSC Adv       Date:  2019-10-23       Impact factor: 4.036

9.  Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses.

Authors:  Katherine A DiScipio; Savithri Weerasooriya; Renata Szczepaniak; Akram Hazeen; Lee R Wright; Dennis L Wright; Sandra K Weller
Journal:  mBio       Date:  2022-01-25       Impact factor: 7.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.